Advanced Search
ZHANG Tao, ZHANGBao-ning, YANG Hong-ying, SUN Yun-tian, LIU Lin, CHEN Sheng-zu. Clinical Significance of Prognosticating Non-SLN Metastasis in Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2005, 32(05): 308-310. DOI: 10.3971/j.issn.1000-8578.2425
Citation: ZHANG Tao, ZHANGBao-ning, YANG Hong-ying, SUN Yun-tian, LIU Lin, CHEN Sheng-zu. Clinical Significance of Prognosticating Non-SLN Metastasis in Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2005, 32(05): 308-310. DOI: 10.3971/j.issn.1000-8578.2425

Clinical Significance of Prognosticating Non-SLN Metastasis in Breast Cancer

  • Objective  In order to avoid axillary dissection in the patient s without lymph node metastases, factors associated with metastases of non-SLN should be found to prognosticate whether non-SLN has metastases. Methods  A database including 116 breast cancer patient s who underwent SLN biopsy between May, 1999 and Febrary, 2004 was reviewed. Using sof t ware SPSS 10. 0 univariate and multivariate analysis were performed to evaluate the relationship between 10 factors and non-SLN metastasis in order to find which factor is associated with metastasis . Results  Tumor size greater than 2cm, lymphatic invasion, c-erbB2 ( + ) were positively correlated with metastasis in non-SLN. When a patient has one factor, the metastasis rate of non-SLN is 91%~95%, when has two factors, the rate is 94 %~100 %, when has three factors, the rate is 100 %. Conclusion  SLN biopsy combined with prognosis of non-SLN help patients with metastases only in SLN to avoid axillary dissection, and then the t reatment will be more purposive than before.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return